ALEXANDRA MCALVANY: Open Payments
NPI 1982313482 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,663 in 200 payments from 23 companies in 2025. Trend: 2023 $1,425 · 2024 $2,546 · 2025 $4,663
Food & beverage: $4,579Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 58 | $1,291 |
| Madrigal Pharmaceuticals | 11 | $509 |
| QOL Medical, LLC | 13 | $398 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $343 |
| Janssen Biotech, Inc. | 13 | $287 |
| PFIZER INC. | 13 | $264 |
| GENZYME CORPORATION | 11 | $233 |
| Ardelyx, Inc. | 12 | $200 |
| Lilly USA, LLC | 11 | $172 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $172 |
Products named: REZDIFFRA, RINVOQ, Sucraid, DUPIXENT, SKYRIZI, TREMFYA, LINZESS, ENTYVIO.
Industry payments across FL — which companies pay providers there.
